Develop appropriate tissue-handling protocols to facilitate molecular testing
Evaluate cytogenetic and molecular techniques including different types of next generation sequencing assays
Recognize cost-effective and time-sensitive approaches to molecular studies in cancer diagnostics
Determine the process of the clinical interpretation of genetic variation
Analyze the costs and potential sources of revenue for molecular diagnostics programs
Consider essential emerging molecular biomarkers in a range of common adult and pediatric solid and liquid tumors
This is an accredited, livestreamed course offered by Brigham and Women's Hospital, Massachusetts Genral hospital, and Boston Children's Hospital. This course is targeted to pathologists, oncologists, and PhD-trained staff working in molecular diagnostic laboratories or in the pharmaceutical industry, as well as trainees in Oncology and Pathology.
Select the Take Course button to view additional information on the course registration page.
Contact ceprograms@hms.harvard.edu with questions.
*Register before July 1 to receive the discounted price.
